These medications can also be expensive and hard to find
Beyond diabetes and obesity, GLP-1s have also emerged as a longevity drug class with research showing potential benefits across inflammation, cardiovascular risk, liver fat reduction, and kidney protection
For oppdatert informasjon om funksjoner, erfaringer og sammenligninger, kan det vre nyttig lese uavhengige omtaler og veiledninger fra kilder med tydelig metodikk og kildehenvisninger
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss
Chronic dry mouth, also known as xerostomia, can make it harder to eat, speak, and even sleep, while increasing the risk of tooth decay and gum disease
Individualized weight loss pharmacotherapy is recommended, based upon factors such as the specific characteristics of each weight loss medication, the presence of weight-related complications, and the medical history of the patient